Search
Login
My Portfolios Login
TradeMachine® Login
CML Research Pro Login
PatternFinder Login
Sign Up
Get TradeMachine®
Get CML Research
Get PatternFinder
Get TradeMachine®
Get CML Research
Get PatternFinder
Compare Products
Home
My Portfolios
CMLViz News
Breaking
Stock
Scanner
Tear Sheet
News
Profile
Stats
Stock Chart
Pivot Points
Financial Charts
Holders
Analysts
Day Trader
Back-Tester
SPX
3,994.15
+36.75
(
+0.92%
)
Dow 30
+0.90%
QQQ
+0.68%
VIX
22.5
-1.65
(
-6.83%
)
Alkermes plc
NASDAQ:ALKS 9:49:06 AM EDT
26.77
+0.14
(
+0.53%
)
Products
FDA Accepts Alkermes' Resubmission Of New Drug Application For ALKS 3831
Published: 12/29/2020 12:19 GMT
ALKS
Alkermes plc (
ALKS
)
- FDA Accepts Alkermes' Resubmission of New Drug Application for Alks 3831.
Alkermes Plc - FDA Sets PDUFA Target Action Date of June 1, 2021.